top of page
4 Companies with FDA Approval Decisions Expected Before the End of January 🗓️
We’re always excited to find bio/pharma companies nearing their therapeutic product launch! These 4 companies have FDA final approval decision (PDUFA) dates before the end of January: Atara Biotherapeutics (NASDAQ: ATRA ) Drug/Therapy: Tab-cel (tabelecleucel) Allogeneic T-cell immunotherapy Indication: Post-Transplant Lymphoproliferative Disease (PTLD) PDUFA date: January 15, 2025 BLA with priority review Biogen (NASDAQ: BIIB ) Drug/Therapy: Leqembi (Lecanemab) IV Maintenance
Jan 5, 2025
4 Companies with FDA Approval Decisions Expected Before the End of January 🗓️
We’re always excited to find bio/pharma companies nearing their therapeutic product launch!
Jan 5, 2025
April 2023 Big Mover™ Stocks and Movers to Watch Report
First posted 3/14/2023; last updated 4/3/23
Mar 14, 2023
Mar 9, 2023
Biopharma Daily Stock Updates - 06/13/22
$XBI $63.32 | -5.53% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #NVAX -10.7% Novavax COVID-19...
Jun 13, 2022
Free Biopharma Daily Stock Updates - 06/13/22
$XBI $63.32 | -5.53% Table of Contents: Covid Updates Pipeline Updates Business Updates Covid Updates #NVAX -10.7% Novavax COVID-19...
Jun 13, 2022
Jump start your biotech due diligence
Our platform helps you uncover your next biotech investment opportunity
bottom of page